Search
Selected: I

IL-1β binding antibodies and binding fragments thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-1β binding antibodies and fragments thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-1.alpha. derivatives and medicament for treating thrombocytop

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-11 muteins

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-12 enhancement of immune responses to T-independent antigens

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-12 inhibition of B1 cell activity

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-12 Stimulation of Neonatal immunity

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-15 mutants having agonists/antagonists activity

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-16 antagonist peptides and DNA encoding the peptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-16 antagonist peptides and DNA encoding the peptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-17 related mammalian cytokine polypeptides (IL-17E)

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-17C related mammalian cytokine polypeptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-18/IGIF chemotherapeutic compositions

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-2 selective agonists and antagonists

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-21 variants

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-4 and IL-10 to downregulate delayed-type hypersensitivity and

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-4 receptor for the therapy, prophylaxis and diagnosis of...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-6 as serum uric acid decreasing compound

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL-7 to stimulate platelet production

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IL1-β Binding antibodies and fragments thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.